An advocacy group has called on the Queensland government to reconsider puberty blocker ban.
A national review found the treatment should remain an option for trans and gender diverse people under 18.
The National Health and Medical Research Council is due to release national guidelines in 2028.
Queensland's deputy premier has rejected the advice of the nation's independent expert health advisory body on the topic of puberty blockers, saying the federal government has taken an "ideological view" on the controversial issue.
Earlier this week, the National Health and Medical Research Council (NHMRC), which is an independent statutory agency, released its interim advice on the use of puberty suppressants in the care of trans and gender diverse people aged under 18, finding the treatment should remain an option.
The NHMRC report said that "based on a shared decision" between young people, parents and clinicians, the medications "can be considered" for a young person who wants puberty suppression.
Described as Australia's "pre-eminent" medical research body by the federal health minister, the NHMRC said healthcare professionals should conduct a comprehensive health assessment before prescribing puberty blockers, and there should be multidisciplinary input and appropriate monitoring.
The 45-page NHMRC report explained that its recommendation for the use of puberty blockers was "conditional"


